Search Login Register

Peptic Esophagitis (Reflux Esophagitis) Summary

Description: INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM.

Also Known As: Reflux Esophagitis; Esophagitis, Peptic; Esophagitides, Peptic; Esophagitides, Reflux; Peptic Esophagitides Show All >>

Networked: 987 relevant articles (139 outcomes, 154 trials/studies) for this Disease

Key Drugs and Agents for Peptic Esophagitis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Omeprazole (Esomeprazole) : 30 outcomes 22 studies in 113 results : FDA 25 Generic
  2. Ranitidine (Zantac) : 17 outcomes 10 studies in 57 results : FDA 63 Generic
  3. lansoprazole (Prevacid) : 12 outcomes 11 studies in 44 results : FDA 15 Generic
  4. Proton Pump Inhibitors : 12 outcomes 6 studies in 55 results : IBA
  5. Proton Pumps (Proton Pump) : 11 outcomes 5 studies in 63 results : IBA
  6. Famotidine (Pepcid) : 10 outcomes 6 studies in 23 results : FDA 72 Generic
  7. pantoprazole (Protonix) : 10 outcomes 6 studies in 21 results : FDA 11 Generic
  8. Sucralfate (Carafate) : 9 outcomes 9 studies in 31 results : FDA 4 Generic
  9. rabeprazole (Aciphex) : 8 outcomes 5 studies in 26 results : FDA 4
  10. Cimetidine (Biomet) : 6 outcomes 11 studies in 38 results : FDA 57 Generic
Show All >>

Diseases Related to Peptic Esophagitis

  1. Gastroesophageal Reflux (GERD)
  2. Stomach Ulcer (Gastric Ulcer)
  3. Duodenal Ulcer (Curling's Ulcer)
  4. Ulcer
  5. Peptic Ulcer (Peptic Ulcers)
Show All >>

Key Therapies for Peptic Esophagitis

Efficacy Chart >>
  1. Gastrectomy : 5 outcomes 8 studies in 102 results
  2. Fundoplication : 3 outcomes 4 studies in 78 results
  3. Drug Therapy (Chemotherapy) : 3 outcomes in 8 results
  4. Gastroenterostomy : 2 outcomes 3 studies in 11 results
  5. Aftercare (After-Treatment) : 2 outcomes 1 study in 9 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.